Servizo
Oncoloxía médica
Publicacións (124) Publicacións nas que participase algún/ha investigador/a
2021
-
A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Nature Communications, Vol. 12, Núm. 1
-
Acquisition of new migratory properties by highly differentiated cd4+cd28null t lymphocytes in rheumatoid arthritis disease
Journal of Personalized Medicine, Vol. 11, Núm. 7
-
Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study
Advances in Therapy, Vol. 38, Núm. 1, pp. 290-303
-
Advanced multi-dimensional cellular models as emerging reality to reproduce In Vitro the human body complexity
International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-28
-
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study
Translational Lung Cancer Research, Vol. 10, Núm. 10, pp. 3902-3911
-
Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol
PLoS ONE, Vol. 15, Núm. 12 December
-
Assessment of saliva and oral candidiasis levels 12, 24 and 36 months after radiotherapy in patients with head and neck cancer
Journal of Stomatology, Oral and Maxillofacial Surgery, Vol. 122, Núm. 6, pp. 566-572
-
BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib
JTO Clinical and Research Reports, Vol. 2, Núm. 3
-
Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging
International Journal of Nanomedicine, Vol. 16, pp. 5923-5935
-
Blood-based protein biomarkers in bladder urothelial tumors
Journal of Proteomics, Vol. 247
-
Breast cancer
Medicine (Spain), Vol. 13, Núm. 27, pp. 1506-1517
-
Breast cancer patient experiences through a journey map: A qualitative study
PLoS ONE, Vol. 16, Núm. 9 September
-
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108
-
Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies
Cancers, Vol. 13, Núm. 12
-
Case-control analysis of the impact of anemia on quality of life in patients with cancer: A Qca study analysis
Cancers, Vol. 13, Núm. 11
-
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 6, pp. 858-871
-
Circulating free DNA and its emerging role in autoimmune diseases
Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-14
-
Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450
-
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab
Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940